Next-Generation Sequencing-Based Evaluation of the Actionable Mutational Landscape in Solid Tumors: the “MOZART” Prospective Observational Study
Francesco Schettini(Target (United States)), Daniele Generali(University of Trieste), Marco Loddo, Cristina Bottin(University of Trieste), Keeda-Marie Hardisty(Centro de Pesquisas Oncológicas), Pablo Rivera(Hospital Clínic de Barcelona), Fabrizio Zanconati(University of Trieste), Giuseppina Ferrero(Istituti Ospitalieri di Cremona), Gareth Williams(King's College London), Marco Ungari(Istituti Ospitalieri di Cremona), Robert Thatcher(Centro de Pesquisas Oncológicas), Sergio Aguggini(Istituti Ospitalieri di Cremona), Marianna Sirico(Istituti Ospitalieri di Cremona), Richard Tancredi(Istituti Ospitalieri di Cremona), Carla Strina(Istituti Ospitalieri di Cremona), Elena Fiorio(University of Verona), Antonio Fioravanti(Istituti Ospitalieri di Cremona), Manuela Milani(Humanitas University), Maurizio Scaltriti(Harvard University), Paul Scorer(Centro de Pesquisas Oncológicas), Nicolò de Manzini(University of Trieste)
Cited by 0
Related Papers
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer
|JNCI Journal of the National Cancer Institute|2007|876
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
|Cancer Discovery|2012|622
The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib
|Cancer Research|2009|298